Accès à distance ? S'identifier sur le proxy UCLouvain
Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer
Onglets principaux
Type de document | Communication à un colloque (Conference Paper) – Présentation orale avec comité de sélection – Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't |
---|---|
Type d'accès | Accès restreint |
Année de publication | 2009 |
Langue | Anglais |
Conférence | "The 44th Annual Meeting of the American Society of Clinical Oncology", (United States) Chicago, IL (du 30/05/2008 au 03/06/2008) |
Information sur le périodique | "Journal of Clinical Oncology" - Vol. 27, no. 13, p. 2231-2237 (2009) |
Peer reviewed | oui |
issn | 0732-183X |
e-issn | 1527-7755 |
Editeur | American Society of Clinical Oncology ((United States) Alexandria, VA) |
Statut de la publication | Publié |
Affiliations |
UCL
- MD/MINT - Département de médecine interne UCL - (SLuc) Unité d'oncologie médicale |
MESH Subject | Quinazolines - administration & dosage - adverse effects ; Pancreatic Neoplasms - drug therapy - mortality - pathology ; Neoplasm Metastasis ; Humans ; Deoxycytidine - administration & dosage - adverse effects - analogs & derivatives ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Antibodies, Monoclonal, Humanized ; Antibodies, Monoclonal - administration & dosage - adverse effects |
Liens |
Référence bibliographique | Van Cutsem, Eric ; Vervenne, Walter L ; Bennouna, Jaafar ; Humblet, Yves ; Gill, Sharlene ; et. al. Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.The 44th Annual Meeting of the American Society of Clinical Oncology ((United States) Chicago, IL, du 30/05/2008 au 03/06/2008). In: Journal of Clinical Oncology, Vol. 27, no. 13, p. 2231-2237 (2009) |
---|---|
Permalien | http://hdl.handle.net/2078.1/86873 |